NCT00088530 2020-02-05BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CTI BioPharmaPhase 3 Completed140 enrolled 15 charts
NCT01197560 2019-11-25Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)CelgenePhase 2/3 Completed111 enrolled 20 charts
NCT02592876 2019-05-17Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell LymphomaSeagen Inc.Phase 2 Terminated81 enrolled 15 charts
NCT00529503 2015-02-25A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCLSeagen Inc.Phase 2 Terminated151 enrolled
NCT00948090 2014-07-31PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma PatientsOtsuka Pharmaceutical Development & Commercialization, Inc.Phase 2 Completed207 enrolled 10 charts
NCT01500161 2013-11-25Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTexas Oncology Cancer CenterPhase 2 Terminated1 enrolled
NCT00002003 2005-06-24Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasNIH AIDS Clinical Trials Information ServicePhase 2 Completed